CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Leqembi records best quarter since launch as Biogen raises guidance

EarningsLeqembiPositive
AI Analysis

Summary

Leqembi generated $184 million in global sales in Q2 2026, its strongest quarter since launch, prompting Biogen to raise guidance.

Financial Highlights

Revenue

$184 million

Guidance

raised

Importance:6/10
Sentiment:
0.70
LeqembiAlzheimer'santi-amyloidsalesguidance raise
Related Companies

Read the original article

Published by Endpoints News on July 29, 2026 10:00 AM

Read Original